Influenza drug companies produce around the clock for 7*24 hours, sales of various influenza drugs have increased.

In recent months, flu activity in China has significantly increased, with the vast majority of provinces entering the flu season. One manufacturer of oseltamivir told reporters that since mid-October, sales of related drugs have increased, and production capacity is currently running 24 hours a day. In addition, several domestic producers of RNA polymerase inhibitors have responded by stating that commercialization efforts for related products are steadily progressing, and the companies have taken various measures to ensure drug supply. The latest data from the Chinese Center for Disease Control and Prevention shows that in terms of the positive rate of respiratory samples from flu-like cases in emergency departments of sentinel hospitals, flu viruses have surpassed adenovirus and respiratory syncytial virus for the first time to take the top spot since the beginning of the autumn and winter season this year.